Amgen to buy Five Prime Therapeutics in $1.9 million deal
Through the latest deal, Amgen will get access to Five Prime’s lead drug candidate, bemarituzumab, which is ready to enter a…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.